Indaptus Therapeutics Inc is trading 11.5% up today at $3.99 as the stock rebounds from a period of high volatility and recent profit-taking.
- Traders appear to be re-entering positions following last week’s multi-day surge and subsequent pullback.
- Broader U.S. equities are trading sharply higher on improved risk sentiment, helping support continued speculative interest in the small-cap biotech sector.